Advertisement

Topics

Trump tax reform uncertainty puts biotech M&A on hold

08:31 EDT 21 Aug 2017 | pharmaphorum

The biotech M&A spree predicted at the beginning of 2017 has failed to materialise, according to a new analysis by Bloomberg. There have just been $11.5 billion in takeovers this year – and although this could all change with one deal, comme...

Original Article: Trump tax reform uncertainty puts biotech M&A on hold

NEXT ARTICLE

More From BioPortfolio on "Trump tax reform uncertainty puts biotech M&A on hold"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...